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Abstract
Ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to 
deoxyribonucleotides to provide the monomeric building blocks for DNA replication and repair. 
Nucleotide reduction occurs by way of multi-step proton-coupled electron transfer (PCET) over a 
pathway of redox active amino acids spanning ~ 35 Å and two subunits (α2 and β2). Despite the 
fact that PCET in RNR is rapid, slow conformational changes mask kinetic examination of these 
steps. As such, we have pioneered methodology in which site-specific incorporation of a [ReI] 
photooxidant on the surface of the β2 subunit (photoβ2) allows photochemical oxidation of the 
adjacent PCET pathway residue β-Y356 and time-resolved spectroscopic observation of the 
ensuing reactivity. A series of photoβ2s capable of performing photoinitiated substrate turnover 
have been prepared in which four different fluorotyrosines (FnYs) are incorporated in place of β-
Y356. The FnYs are deprotonated under biological conditions, undergo oxidation by electron 
transfer (ET) and provide a means by which to vary the ET driving force (ΔG°) with minimal 
additional perturbations across the series. We have used these features to map the correlation 
between ΔG° and kET both with and without the fully assembled photoRNR complex. The 
photooxidation of FnY356 within the α/β subunit interface occurs within the Marcus inverted 
region with a reorganization energy of λ ≈ 1 eV. We also observe enhanced electronic coupling 
between donor and acceptor (HDA) in the presence of an intact PCET pathway. Additionally, we 
have investigated the dynamics of proton transfer (PT) by a variety of methods including 
dependencies on solvent isotopic composition, buffer concentration, and pH. We present evidence 
for the role of α2 in facilitating PT during β-Y356 photooxidation; PT occurs by way of readily 
exchangeable positions and within a relatively “tight” subunit interface. These findings show that 
RNR controls ET by lowering λ, raising HDA, and directing PT both within and between 
individual polypeptide subunits.
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 INTRODUCTION
Enzymatic electron transfer (ET) plays a central role in biological energy transduction.
Catalytic cofactors face the formidable challenge of maintaining control over highly reactive 
species within the milieu of the protein scaffold. This feat is particularly remarkable when 
ET processes involve the formation of amino acid radical intermediates, the reversibility of 
which is dictated by the surrounding environment. Such events are usually coupled to the 
transfer of a proton via proton-coupled ET (PCET).– The coordination of proton and 
electron is critical to the function of ribonucleotide reductase (RNR), whose catalytic ability 
to convert ribonucleotides to deoxyribonucleotides relies on reversible long-range PCET 
spanning two subunits and ~35 Å (Figure 1). The active form of the class Ia RNR from E. 
coli is composed of two obligate homodimers, α2 and β2 (Figure 1)–. The α2 subunit 
contains the active site, as well as additional binding sites for allosteric effectors that control 
both overall activity, and substrate specificity. The β2 subunit contains the diferric–tyrosyl 
radical cofactor, FeIII2(μ−O)/Y•, responsible for initiating active site chemistry. 
Translocation of this stable radical in the β2 subunit, to the active site in the α2 subunit 
occurs by way of multi-site PCET hopping over a pathway of redox active amino acids., The 
RNR mechanism begins with substrate binding in α2,, which triggers a conformational 
change resulting in proton transfer from a water molecule ligated to the differic co-factor to 
the stable β-Y122•. Simultaneous ET results in oxidation of β-Y356,, exemplifying 
orthogonal, or bidirectional PCET. From here, PCET across the subunit interface 
sequentially oxidizes α-Y731, α-Y730,, and then α-C439 (Figure 1 inset), via collinear PCET
(in which protons and electrons are mutually exchanged between the same donor and 
acceptor partners). Upon oxidation, α-C439• initiates active site chemistry by hydrogen atom 
abstraction from substrate.– Multi-step substrate-based radical chemistry follows,, after 
which reverse PCET carries the radical “hole” back to its stable resting state at Y122 in β via 
the same PCET pathway.
To measure the kinetics of PCET events in RNR, we have developed phototriggering 
methods to bypass rate-determining conformational changes. This methodology has enabled 
detailed studies of photoinitiated substrate turnover, spectroscopic observation of 
photogenerated radicals, and measurement of both radical injection rates into α2, and radical 
propagation rates through α2 to the active site. A photochemically competent β2 subunit
(photoβ2) is prepared by installing three mutations (C268S, C305S, and S355C) to render a 
single cysteine residue surface-exposed, and facilitate site-specific conjugation of a 
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bromomethylpyridyl rhenium(I) tricarbonyl phenanthroline complex ([ReI]) to position β355 
via an SN2 reaction. Recently, we extended this methodology by incorporating 2,3,5-F3Y at 
position β356 via nonsense codon suppression methodology (Figure 1, inset). This allowed 
direct observation of photogenerated radicals by transient absorption (TA) spectroscopy and 
elucidation of the kinetics for radical propagation steps through α.
Little is known about the structure and dynamics occurring at the RNR subunit interface. 
Not only is a complete crystal structure of the α2β2 complex absent, but structures of the β2 
and α2 subunits alone all lack structural information regarding the key redox active residue 
β-Y356. Herein, we unveil new aspects of the molecular and intermolecular interactions 
governing charge transfer within the RNR subunit interface by modulating the driving force 
through incorporation of unnatural amino acid fluorotyrosines (FnYs), whose unique 
electrochemical and acid/base properties allow systematic correlation of kET and ΔG°, as 
well as dependencies on pH, buffer concentration, and solvent isotopic composition. A series 
of photoβ2s have been prepared in which four different FnYs (n = 2−3) are incorporated at 
position β356. Each of these photoβ2s is capable of photochemical substrate turnover, and 
they demonstrate reactivity that depends on the oligomeric state (dictated by allosteric 
effectors), highlighting an allegiance to wt-RNR chemistry. The FnYs used here display a 
range of reduction potentials (Figure 2), yet incur only small perturbations relative to each 
other across the series. These features, coupled with the fact that FnYs can exist in their 
deprotonated forms under biologically compatible conditions, render the series of photoβ2s 
ideally suited for examination of the relationship between kET and ΔG° within the unique 
dielectric environment of a protein/protein interface.
By examining the relationship between kET and ΔG°, we have found that the photooxidation 
of FnY356 occurs within the Marcus inverted region. From the Marcus curve, we estimate 
that λ ≈ 1 eV within the α/β subunit interface, and that the presence of an intact PCET 
pathway increases the electronic coupling between donor and acceptor. Through this work 
we have uncovered a distinct role of the α2 subunit in facilitating PT during β-Y356 
oxidation. We have further elaborated our studies by examining the PCET kinetics as a 
function of pH, solvent isotopic constitution, and buffer concentration all as a function of 
oligomeric state and in the presence and absence of the next PCET pathway residue, α-Y731. 
Our data support a model for the PT pathway that exhibits tightly bound, yet solvent 
exchangeable protons that assist the intersubunit ET.
 EXPERIMENTAL SECTION
 Materials
Wt-α2 (2,000 nmol/mg/min) was expressed from pET28a-nrdA and purified as previously 
described. A glycerol stock of Y731F-α2 was available from a previous study, and was 
expressed and purified as wt-α2. All α2 proteins were pre-reduced and treated with 
hydroxyurea (HU, Sigma Aldrich) by incubation with 30 mM dithiothreitol (DTT, Promega) 
for 30 min at room temperature, then addition of 15 mM more DTT and 15 mM HU, 
followed by buffer exchange on a Sephadex G-25 or G-50 column. [5-3H]-cytidine 5′-
diphosphate sodium salt hydrate ([5-3H]-CDP) was purchased from ViTrax (Placentia, CA). 
2,3,5-Trifluoroboronic acid, 2,3,6-trifluorophenol, 2,3-difluorophenol, and 3,5-
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difluorophenol were commercially available (Sigma Aldrich). Tricarbonyl(1,10-
phenanthroline)(4-bromomethyl-pyridine)rhenium(I) hexafluorophosphate ([ReI]–Br) was 
available from a previous study. E. coli thioredoxin (TR, 40 μmol/min/mg) and thioredoxin 
reductase (TRR, 1,800 μmol/min/mg) were prepared as previously described., Flurotyrosines 
were synthesized enzymatically from pyruvate, ammonia, and the corresponding 
fluorophenol with tyrosine phenol lyase as previously described. Assay buffer consists of 50 
mM HEPES, 15 mM MgSO4, and 1 mM EDTA adjusted to the specified pH.
2,3,5-Trifluorophenol was synthesized according to published procedures for related 
fluorophenols as summarized briefly below. 1.2 equiv H2O2 (34 mmol; 3.9 mL of a 30% v/v 
solution) was added to a stirring slurry of 5.00 g (28.4 mmol) 2,3,5-trifluorophenylboronic 
acid in 100 mL water. The reaction was allowed to stir overnight at room temperature during 
which time the insoluble starting material is converted to the soluble product. Addition of 
100 mL 1 M HCl was followed by extraction twice into 100 mL CH2Cl2 and solvent 
removal in vacuo. The product was collected in 85% yield. TLC (4:1 Hexanes: EtOAc) Rf = 
0.45. 1HNMR 19F NMR chemical shift match previously reported spectra.
Photoβ2s were prepared as previously described with yields listed in Table S1. Assessment 
of Y122• content was performed by the dropline method and enzymatic activity was (Table 
S1) assessed as previously described, briefly outlined in the SI. Assessment of purity was 
performed by 10% SDS-PAGE (Figure S1). Labeling with [Re]-Br was performed as 
previously described by addition of a small volume of 5 equiv [Re]-Br in DMF to protein 
that has been reduced with DTT and buffer exchanged into 50 mM Tris, 5% glycerol at pH 
8.0. Incubation at room tempertaure for 2 h was followed by buffer exchange via Sephadex 
G-25 size exclusion chromatography. Addition of 30 mM hydroxyurea (HU) to reduce Y122• 
and incubation at room temperture for 30 min preceded a final round of buffer exchange into 
assay buffer.
Photochemical single turnover experiments were performed as previously described.,,,
Additional controls for the observed photochemical reactivity of photoβ2s were examined in 
conjunction with Y731F-α2 and [Re]-Y356F-β2 are presented in Figure S2.
pKa titrations were performed as previously described. Samples contained 5 μM photoβ2, 20 
μM wt-α2, 1 mM CDP, 3 mM ATP in 15 mM MgSO4 and 1 mM EDTA and 50 mM of one 
of the following: MES: pH 5.4 – 6.8; HEPES: pH 6.8 – 8.0; TAPS: pH 8.2 – 9.0. 
Measurements were performed in a 0.4 cm quartz cuvette held at 25 °C with λexc = 315 nm 
and emission detected over 450–650 nm in conjunction with a 420 nm long-pass cutoff filter.
Nanosecond laser flash photolysis was performed with a system that has previously been 
described. Optical long-pass cutoff filters (λ > 375 nm) were used before detection to 
remove scattered 355 nm pump light. Slit widths corresponding to ± 1 nm resolution were 
used and the laser power set to 2 mJ/pulse. All transient spectroscopy samples were prepared 
in a 500 μL volume containing 10 μM photoβ2, 25 μM α2 (or variant), 1 mM CDP and 3 mM 
ATP or 200 μM dATP in assay buffer. Samples were recirculated through a peristaltic pump 
to attenuate sample decay. Each measurement is an average over 1000 laser shots and was 
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performed in triplicate on independently prepared samples, with the exception of pH 
dependence data, in which measurements were performed only in duplicate.
Analysis of kinetics data was performed by fitting each emission decay trace to Eq. 1 over 
the span of 0.1–4.5 μs using OriginPro 8.0 software (OriginLab). Acceptability of fitting was 
determined on the basis of qualitative symmetry of residuals about zero amplitude and the 
R2 factor. Exemplary traces and residuals are available in Figure S3.
(1)
Under each experimental condition two sets of lifetime (τ) data were obtained in order to 
calculate kET or kPCET. These two τ values correspond to the [ReI]* lifetime measured 
(under each experimental condition) with the photoβ2 containing F at position β356 (τo, green 
in Scheme 1) and with the photoβ2 containing Y or FnY at position β356 (τY, purple in 
Scheme 1). Plugging these numbers into Eq. 2 then yields the rate constant for the relevant 
pathway of [ReI]* quenching, namely Y or FnY oxidation.
(2)
The absolute uncertainty of each k(PC)ET (δ) was calculated according to Eq. 3 below, where 
σ represents one standard deviation among each set of lifetime data (τ). As a result of high 
S/N in these experiments, the error associated with the fitting process was consistently close 
to three orders of magnitude smaller than the lifetime value itself. As such, this error was 
insignificant relative to the standard deviation between replicates.
(3)
Dependence of kPCET on oligomeric state was ascertained by conducting emission 
quenching experiments as outlined above in assay buffer (15 mM MgSO4, 1 mM EDTA, 50 
mM HEPES adjusted to pH 7.6) containing either 1 mM CDP and 3 mM ATP to promote 
the active α2β2 oligomer, or 200 μM dATP to promote the inactive α4β4 oligomeric state.
Solvent isotope effect samples were prepared by lyophilizing 4× concentrations of assay 
buffer followed by rehydration in D2O. The buffer pL was adjusted to 7.6 for all samples by 
addition of NaOD or NaOH according to Eq. 4.
(4)
All protein samples used were exchanged into [2H]-assay buffer by 5 cycles of 5-fold 
concentration followed by resuspension using pre-soaked 30 kDa MWCO centrifugal filters 
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(Millipore) to ensure that <3% H2O remained in D2O samples. Samples prepared in [1H]-
assay buffer were treated identically to ensure that any effect of this treatment was identical 
for all samples under study.
pH dependence of k(PC)ET was performed by measuring emission lifetimes as outlined above 
with samples containing 1 mM CDP, 3 mM ATP in assay buffer containing 50 mM of one of 
the following: MES: pH 5.4–6.8; HEPES: pH 6.8–8.0; TAPS: pH 8.2–9.0, adjusted to the 
appropriate pH. In these experiments the emission is quenched much more rapidly (where 
the forward and reverse rates occur simultaneously to set up an equilibrium) when FnY is 
deprotonated, thus revealing the pKa by a sharp reduction in the total emission intensity.
 RESULTS
In order to assess the influence of the protein environment on ET kinetics, a series of 
phtotoβ2s were prepared in which four different FnYs (Figure 2) are incorporated at position 
β356. In this way, the driving force for electron transfer from FnY− to [ReI]* was varied over 
~150 mV while incurring minimal additional perturbations across the series. The 
dissociation constant for photoβ2 binding to α2 is 0.7 ± 0.1 μM. This value reveals that 
incorporation of the [ReI] complex incurs only a small disruption to the subunit interaction, 
as the Kd for wt-RNR is 0.2 μM. Of the six photoβ2s under study, only that with 3,5-F2Y 
displayed native enzymatic activity in its holo-state (still containing the Y122• cofactor, prior 
to reduction with HU). The specific activities measured before and after labeling with [ReI] 
were 1000 and 300 nmol(min-mg)−1, respectively for this photoβ2 (Table S1). For reference 
wt-β2 has specific activity of 6000 nmol(min-mg)−1. The photoβ2 with Y at position 356 
exhibits specific activities of 2300 and 200 nmol(min-mg)−1, before and after labeling with 
[ReI], respectively. In both of these cases (3,5-F2Y and Y), the activity prior to labeling 
exhibits nonlinear behavior due to the oxidation of S355C. The activity is linear after labeling 
with [ReI] because the thiol is converted to a thioether, which is more difficult to oxidize. 
The fact that Y and 3,5-F2Y are the easiest Y-derivatives in the series to oxidize coincides 
with the fact that these are the only two photoβ2s exhibiting non-photochemical activity.
 Photochemical turnover
We sought to confirm that these photoβ2s are photochemically competent for turnover. To 
this end, we performed single turnover experiments under white light illumination in the 
presence of radiolabelled substrate (Figure 3). We note that in all cases the native Y122• 
cofactor within the photoβ2s has been quantitatively reduced by treatment with HU, 
rendering them incapable of undergoing turnover via the non-photochemical mechanism. 
Residual reactivity can be seen in the amount of turnover observed in the dark (green bars, 
Figure 3). Similarly, control experiments with variants containing redox-inactive pathway 
substitutions exhibit very low background levels of product formation under illumination 
(Figure S2).
Two methods for the photochemical generation of FnY• have been implemented in this 
work. In the direct method, (Scheme 1, purple) the excited state 3[ReI]* complex oxidizes 
the adjacent Y-derivative directly.,,, A second method, utilizes flash-quench methodology 
where, in the presence of excess Ru(NH3)6Cl3, the excited state 3[ReI]* is oxidized via 
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bimolecular reaction with Ru(NH3)63+, yielding Ru(NH3)62+ and [ReII]. This [ReII] species 
then oxidizes FnY (Scheme 1, blue). These two photochemical generation methods were 
implemented under single turnover conditions for all photoβ2s. Wt-RNR can generate a 
theoretical maximum of 4 dCDP products per α2 subunit, one for each α monomer, and a 
second per monomer arising from the re-reduction of active site cysteines (α-C225 and C462) 
by disulfide exchange with two C–terminal cysteines (α-C754 and C759); this maximum is 
diminished for wt-β2 under flash-quench conditions (Figure 3, right). Notwithstanding, all 
photoβ2s exhibited the ability to produce products via photochemical activation (Figure 3), 
lending confidence that our method retains authenticity to RNR.
 Oligomeric state
RNR exists naturally as a dimer, but can enter a complex equilibria involving oligomeric 
forms (α2, β2, α2β2, and α4β4) as dictated in vivo by the presence of allosteric effectors and 
substrates., The formation of an inhibited complex, the α4β4 oligomeric state, occurs at the 
high protein concentrations often required for in vitro biophysical measurements. Because 
the total protein concentration (35 μM) of our spectroscopic experiments may engender the 
inactive α4β4 state, we needed to establish the presence of α2β2 dimer in our experiments. 
The inhibited α4β4 state is favored for dATP concentrations >100 μM, whereas the active 
form is known to exist (at least transiently) in the case where ATP and CDP are present. We 
used these facts to investigate which oligomeric state(s) predominate under our experimental 
conditions. Under the conditions of ATP and CDP, we observe a 34% enhancement in kPCET 
(with the photoβ2 containing Y at position 356) in the presence of wt-α2 relative to Y731F-α2 
(Table 1). We have previously ascribed this enhancement to a dependence on the presence of 
an intact PCET pathway. On the contrary, in the presence of 200 μM dATP (promoting the 
α4β4 state), identical kPCET values were obtained in the presence of wt-α2 and Y731F-α2 
(Table 1). These results are consistent with the structure of the α4β4 oligomer, which unlike 
the globular form of the active α2β2 complex, forms a donut-shaped oligomer. The C-termini 
of β2 remain bound to α2 in this state, giving rise to exposure of Y356 to bulk solution. Thus 
Y731 of the α2 subunit is not adjacent to Y356 in the α4β4 oligomer and the PCET pathway 
from β2 to the neighboring α2 subunit is disrupted. Hence the photooxidation of Y356 within 
the inhibited oligomeric form should be unaffected by the presence or absence of α-Y731; 
the data in Table 1 show this to be the case. The results of Table 1 therefore establish that the 
photoβ2α2 state exists under normal experimental conditions in which CDP and ATP are 
present and that we are examining photooxidation events within the subunit interface of the 
active α2β2 complex.
 Energetics
The overall free energy change accompanying the generation of the photoβ2 charge-
separated state is schematically represented in Figure 2 and given by,
(5)
[ReI] and FnY− initially have equal and opposite charges that are neutralized upon ET; the 
additional contribution to ΔG° from an electrostatic work term is negligible. The excited 
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state emission energy was determined from the low temperature (77 K) emission spectrum 
of [Re]-Y356F-β2 as previously described to yield ΔGMLCT of 2.73 eV (Figure S4). A shift in 
this value is not observed when the measurement is performed in the presence of the α2 
subunit. The ground state reduction potential of [ReI(phen)(CO)3EtPy]-PF6 has previously 
been reported to be −0.79 V vs NHE. As summarized on the Latimer diagram of Figure 4, 
from these values, the excited state reduction potential is calculated to be E°([ReI]*/[Re0]) = 
1.94 V vs NHE.
The FnY reduction potentials were measured by differential pulse voltammetry (DPV) with 
the N-acetyl C-amide protected amino acid derivatives (Figure S5). The propensity of 
tyrosine to undergo fast bimolecular chemical reactions following its one-electron oxidation 
has precluded accurate determination of the thermodynamic (reversible) reduction 
potentials. However, evidence from de novo protein model systems in which redox active 
amino acids are sequestered from solution, the reversible reduction potentials for both Y and 
3,5-F2Y have been determined. In each case, the absolute values of E°′ differ by ~150 mV 
from those determined by DPV. However, the relative potentials of Y and 3,5-F2Y (ΔE°′ = 
30 mV at pH 5.7), remain very close to the relative potentials measured by DPV (ΔEp = 50 
mV, pH 5.7). Thus, in the current work we apply the assumption that all FnYs within the 
subunit interface will be subject to similar perturbations, prompting the caveat that all ΔG°s 
may be shifted and that values are to be interpreted as relative rather than absolute. We note 
that rapid freeze quench electron paramagnetic resonance (RFQ-EPR) spectroscopy of 
radical equilibration along the PCET pathway reveals that β-Y356 is about 100 mV easier to 
oxidize than the adjacent α-Y731 residue but we have not included any correction factors in 
our calculations of ΔG° herein and simply reiterate the aforementioned caveat.
The pKas of the FnYs within the photoβ2α2 complex (Table 2) are obtained by measuring the 
intensity of steady-state [ReI]* emission as a function of pH. Figure 5 shows the normalized 
integrated emission intensity (I) as a function of pH. The pKa is afforded from fitting these 
data to the following,
(6)
Only slight differences are found between the pKas for FnYs in the protein and the 
corresponding N-acetyl C-amide protected FnYs. As previously observed for RNR, there is 
little perturbation to the phenolic pKas at position β356 within the complex.
Based on these data, experiments to examine the kinetics of ET for the photoβ2s were 
conducted at pH 8.2 such that the FnYs are nearly fully deprotonated. Accordingly, the 
reduction potentials to be used in Eq. 5 were taken from the pH-independent regions of DPV 
Pourbaix diagrams (Figure S5). For the cases of Y and 2,3-F2Y (which is only ~80% 
deprotonated at pH 8.2), the Nernst equation (Eq. 7) was applied to calculate the reduction 
potentials under the experimental conditions.
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(7)
With the excited stated reduction potential of 3[ReI]* and each FnY− in hand, the driving 
force for photogeneration of each charge-separated state may be determined from Eq. 5.
 Electron Transfer Kinetics
The excited state lifetime of 3[ReI]* (τ) for each photoβ2 was measured by nanosecond laser 
flash photolysis (in the absence of flash quencher). The rate constant for the formation of the 
charge-separated state resulting from 3[ReI]* reduction via FnY oxidation may be 
determined from Eq. 2, where τ for photoβ2s containing Y or FnY at position β356 is 
referenced to τo for Y356F-photoβ2 (purple versus green in Scheme 1). In this way, all 
pathways for 3[ReI]* decay besides that proceeding via FnY oxidation are accounted for and 
kET represents the rate constant of only the relevant reaction. The rate constants summarized 
in Figure 6 were determined from measurements in triplicate for each photoβ2 alone, in the 
presence of wt-α2, and in the presence of Y731F-α2. The latter experiment was performed as 
a control wherein the α2β2 complex is intact but charge injection into α2 is prevented; thus it 
is a measure of the decay of the photogenerated radical within the β2 subunit of a fully 
assembled system. Experiments with α2 variants were conducted at protein concentrations 
such that >95% of the photoβ2 moiety was in complex with α2, based on the Kd measured 
for photoβ2α2 dissociation of 0.7 ± 0.1 μM. All samples contained saturating concentrations 
of substrate (CDP) and effector (ATP) in order to ensure binding in an active conformer 
(Table 1). A detailed account of our interpretation and analysis of these data is included in 
the Discussion section, wherein the data are replotted and overlaid with simulations of the 
semiclassical Marcus relation (Eq. 9).
The effects of solvent isotopic composition, buffer concentration, and pH, on the kinetics of 
charge transfer at the interface were examined, both in the presence and absence of α2 and 
the Y731F-α2 variant. We note that where Y, or a protonated FnY is positioned at β356 we 
have labeled the corresponding rate constants with kPCET rather than kET. Solvent kinetic 
isotope measurements (SKIE) of the photooxidation of Y356 occurs with SKIE ~1.5 under 
all three conditions listed in Table 3. Such isotope effects are observed– and theoretically,
predicted when the PCET involves electron transfer through a hydrogen bond. This 
observation of a small isotope effect suggests that proton acceptor(s) reside in positions that 
are hydrogen bonded and are readily exchangeable with solvent. This holds both in the 
presence and absence of α2, and regardless of whether or not the PCET pathway is intact. 
Alternatively, a modest to negligible value may be the result of viscosity and/or pKa 
differences resulting from the different properties of the two buffers.
Figure 7 displays the results of the dependence of kPCET on buffer concentration. The effects 
are small when compared to similar studies performed with small molecule model systems 
in solution, in which kPCET may change by an order of magnitude over similar ranges of 
buffer concentration., Unlike studies with small molecules, we also find that a dependence 
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on buffer concentration is manifest only at low concentrations. These data suggest that the 
subunit interface is relatively protected from solvent species. The dependence that we do 
observe is slightly larger in the presence of wt-α2 relative to Y731F-α2. This may implicate a 
role for α-Y731 in facilitating PT from β-Y356, although it has been shown that this residue 
does not interact directly with β-Y356.
To further probe the extent that the α2 subunit facilitates PT during photooxidation of β-Y356 
(either by specific residues or by dictating conformation), the pH dependence of kPCET and 
kET below and above the phenolic pKa of 2,3-F2Y-photoβ2 was examined. This FnY was 
selected because it has a pKa of 7.8 (Figure 5, Table 2), in the middle of the pH range that is 
accessible for the class Ia RNR. Figure 8 summarizes the pH dependence of photooxidation 
of this residue with the photoβ2 alone, or in the presence of wt- or Y731F-α2. In the absence 
of α2, kPCET increases linearly with pH up to the phenolic pKa, after which a sharp break 
occurs. Conversely, in the presence of α2 continuous behavior is observed over the entire pH 
range examined. This result supports the contention that α2 facilitates PT during β-Y356 
photooxidation.
 DISCUSSION
RNR maintains control over long-range PCET events by way of well-choreographed 
conformational dynamics.,,, Kinetics measurements suggest that the PCET pathway is finely 
tuned and that it is the target of the conformational gating. ,,, Crystallographic elucidation of 
the active α2β2 structure, however, has not been achieved so the structural details of 
conformational gating and its relation to radical transport via PCET remain to be elucidated. 
Some structural insight is provided from shape and charge complementarity studies of the 
separately crystallized subunits, furnishing the so-called α2β2 docking model (Figure 1), as 
supported by cryogenic electron microscopy (cryoEM), small angle x-ray scattering 
(SAXS), and pulsed electron-electron double resonance (PELDOR) spectroscopy with 
metastable trapped states of the α2β2 complex.– Nonetheless, the last 25–30 amino acids 
remain disordered in the available structures of the β2 subunit. It is this C-terminal tail of β, 
specifically the last 15 residues, that is largely responsible for binding interactions with the 
α2 subunit and importantly the structurally disordered portion includes the key redox-active 
Y356, which mediates charge transfer at the interface of the α2 and β2 subunits.
Owing to this disorder, the specific molecular interactions within the α2β2 subunit interface 
remain largely unknown. More generally, insights have emerged from high-field EPR and 
[2H]-electron nuclear double resonance (ENDOR) spectroscopies in which radicals are 
trapped en route to the active site by a genetically encoded NH2Y residue to furnish a 
spectroscopic handle for examining hydrogen bonding (H-bonding) interactions along the 
PCET pathway. This work has revealed strong collinear H-bonding between α-Y731 and α-
Y730, and that no such strong and/or static H-bonding interactions exist at position Y356.
However, large shifts in gx values for β-Y356 do persist, suggesting that the dielectric 
medium of the interface is strongly perturbed within the active complex despite the absence 
of distinct H-bonds.
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To directly investigate charge (electron and proton) dynamics at the interface, we have 
examined radical formation at the β-Y356 position within the α2β2 subunit interface by using 
fluorinated tyrosines. These unnatural amino acids allow charge transfer to be examined 
over a sizable driving force range according to the Marcus relation,
(8)
where the electronic coupling HAD exhibits an exponential dependence on the distance 
between donor and acceptor (r) relative to the van der Waals contact distance (ro),
(9)
kET is related to ΔG° via reorganization energy λ and electronic coupling matrix element 
HAD. For the homologous series of FnYs, λ and HAD may be assumed to be similar across 
the series and hence the correlation between ln(kET) and ΔG is straightforward. In this case, 
the parabolic relationship between ln(kET) and ΔG° predicts that an increase in ΔG° results 
in faster rates when λ > |−ΔG°| and slower rates when λ < |−ΔG°|, known as the Marcus 
inverted region.
For the study reported herein, over the pH regime examined, the FnYs are deprotonated and 
radical generation in β-FnY356 is consequently well described by a pure ET. As Figure 6 
shows, kET decreases with increasing driving force, a clear signature of Marcus inverted 
behavior. Entry into the Marcus inverted regime is largely a result of the high excited state 
reduction potential of 3[ReI]* (1.94 V vs NHE).
Figure 9 shows a simulation of Eq. 8. The Marcus simulations were performed using a full 
range of possible distances (r = 4–16 Å, Table S2) accounting for all reasonable 
conformations of the [Re]−C−FnY fragment (Figure S6). Regardless of which value of r is 
selected, the relative ratios of HAD values under the different conditions remain the same 
(Table S2), facilitating qualitative comparisons to be made. The range of ΔG° spanned by 
the FnY-photoβ2s (~150 mV) did not permit accurate fitting of Eq. 8. As such, the dashed 
lines of Figures 9 and 10 represent simulations of Eq. 8. The parameters used in these 
simulations represent the best agreement with the measured values. The data in Figure 9 
were simulated with λ = 0.98 eV, a value that is approximately half that found for model 
[Re]-FnY systems (λ = 1.9 eV). The lower λ for the RNR complex indicates that the subunit 
interface has evolved to facilitate inter-protein charge transfer, shielding reactive radical 
intermediates from the bulk solvent by lowering λ, yet all without precluding the required 
concomitant PT (vide infra). This result is in line with the general observation that λ within 
the protein environments is depressed as a result of a combination of the constraints imposed 
on dipole motions due to their confinement within the polypeptide matrix, as well as the low 
dielectric permittivity within the protein.– Conversely, ET across weakly bound protein-
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protein complexes, or involving solvent-exposed cofactors incur higher reorganization 
energy penalties.–
We note that the curve in Figure 9 for β-FnY356 in the presence of wt-α2 is higher than that 
for β-FnY356 in the presence of Y731F-α2 indicating greater electronic coupling for charge 
transfer in the former complex. The simulation of data for the β-FnY356:wt-α2 complex 
furnished HAD = 0.051 cm−1 vs. HAD = 0.044 cm−1 for the β-FnY356:Y731F-α2 complex. 
This result is consistent with our previous results that show charge transfer is facilitated by 
delocalization of the radical over the Y731-Y730 dyad of α2. When the Y-Y dyad is disrupted 
by a Y → F substitution in α2, radical propagation by charge transfer is attenuated.,
Accordingly, we ascribe the higher HAD in the wt complex to delocalization of the hole 
across the adjacent Y731 residue, a process that is precluded when Y731F is present. From 
the work of Beratan et al., the amplitude of HAD determined from our data (4 × 10−11 eV) 
falls within a regime that implicates an ordered network of water molecules and H-bonding 
interactions within the subunit interface. This result is in line with the small SKIE (Table 3) 
that we observe, further supporting the presence of water molecules within the α/β interface 
that facilitate rapid proton exchange at β-Y356. The presence of a network of water 
molecules is also consistent with the lack of observed signals for strong and static H-bonds 
at position Y356 by ENDOR spectroscopy.
In the case of Y, tyrosine largely resides in its protonated state at pH 8.2. However, within 
the α2β2 complex, the protonated β-Y356 follows the trend of the deprotonated β-FnY356s. 
The rate constant for the former is smallest, as the system exhibits the largest driving force 
and hence falls deepest into the inverted region. In contrast, when uncomplexed, the 
protonated β-Y356 exhibits anomalous behavior from the deprotonated FnYs. Because charge 
transfer is occurring in the inverted region, the faster rate for the photoβ-Y356 implies a 
greater activation barrier for charge transfer. Indeed a simulation of the ET reaction of the 
photoβ-FnY356 yields λ = 0.74 eV whereas for photoβ-Y356 a value of λ = 0.90 eV is 
obtained (Figure 10). This simulated curve is presented only to illustrate the graphical 
repercussions of changing only the value of λ in the simulated curve and does not represent 
robust support. The difference of 160 mV is entirely consistent with the requirement of PT 
accompanying ET for the oxidation of tyrosine.
Calculations comparing reorganization energies for concerted PCET versus stepwise ET/PT 
charge transfer mechanisms in model systems find differences in λ of 134 mV; moreover 
experimental studies show that the PCET versus ET pathways in model systems incurs 
higher reorganization energies of 60–500 mV.– The data in Figures 7 and 8 are also 
consistent with tyrosine oxidation by PCET in photoβ-Y356. Exposed to solution, the rate of 
reaction is accelerated by the presence of buffer (Figure 7), which provides a facile acceptor 
for the proton in the PCET reaction. Moreover, pH dependence of the rate of 2,3-F3Y 
oxidation in the 2,3-F2Y-photoβ shows a discontinuity at the pKa of the 2,3-F2Y (Figure 8), 
also consistent with a PCET process. It is noteworthy that the PCET kinetics are accelerated 
when the PCET pathway is fully assembled within an α2β2 complex. Whether via 
organization of the C-terminal tail of β, or through specific interactions with amino acid 
residues in α, or both, the PCET process for Y oxidation in the presence of α2 appears to 
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behave kinetically like an ET process. These data highlight the exquisite control that RNR 
maintains over reactivity, engendered in part by managing PCET at the protein interface.
 CONCLUSION
Radical transport in RNR occurs across two subunits along a PCET pathway that is 
emerging as the target of conformational gating within the enzyme. A critical step along the 
PCET pathway occurs at the subunit interface where PCET is proposed to transitions from a 
bidirectional to a collinear PCET pathway., To probe charge transport among the critical 
amino residues across the interface, we have introduced a series fluorotyrosines in photoβ2, 
thus allowing for the modulation of the free energy driving force and protonation state of 
residue β356. With this method, few additional perturbations between variants are incurred, 
allowing for the extraction of the energetics and electronic coupling of charge transport at 
the RNR interface. We have shown that each photoβ2 is photochemically competent and that 
rate constants for photoxidation depend on maintaining the active oligomeric state via the 
presence of allosteric effectors. Analysis of the correlation between kET and ΔG° reflects the 
ability of the protein to minimize the reorganization energy and increase electronic coupling 
at the protein-protein interface in the presence of the intact PCET pathway. Additionally, we 
present evidence that the α2 subunit facilitates PT from β-Y356, and that this process occurs 
via solvent exchangeable protons, within a tightly bound subunit interface. Our data add to 
mounting evidence that PCET through RNR is controlled by way of macromolecular 
conformational changes targeting the precise alignment of the PCET pathway.
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Figure 1. 
Docking model of the active E. coli class Ia RNR, an α2β2 complex. α2 (blue and green) co-
crystalizes with a peptide corresponding to the 15 C-terminal residues of β (yellow) (ref 35). 
β2 crystallizes up to residue 340 (red and orange) (ref 36). Photoβ2s are prepared via 
cysteine ligation of a [ReI] complex at position 355, and incorporation of a fluorotyrosine at 
position 356 (inset). Due to the absence of structural information for residues 341–359 of β, 
attachment of the [ReI]-S355C-F3Y356 fragment is illustrated by dashed lines (red leading 
from the crystalline β subunit, yellow leading to the C-terminal peptide bound to α).
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Figure 2. 
Photooxidation of β-FnY356 by the metal-to-ligand charge transfer (MLCT) excited state of 
[ReI]*. Variation of the driving force for this process is achieved by incorporation of various 
FnYs at position β356. Peak potentials are taken from differential pulse voltammetry 
performed on the N-acetyl C-amide-protected amino acid derivatives.
Olshansky et al. Page 18
J Am Chem Soc. Author manuscript; available in PMC 2016 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. 
Photochemical single turnover experiments in the presence (blue) and absence (purple) of 10 
mM Ru(NH3)6Cl3. Control experiments (green) were performed in the dark. Samples 
contained 10 μM (blue) or 20 μM (purple and green) of photo- or wt-β2 as indicated along 
the x-axis, 10 μM wt-α2, 200 μM [5-3H]-CDP with 27,000 cpm/nmol radioactivity, 3 mM 
ATP, in assay buffer at pH 7.6. Error bars represent 1 s.d. for 3 independent trials.
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Figure 4. 
Latimer diagram describing excited state reduction potentials of [ReI]. ΔGMLCT determined 
from the E0/0 emission of [Re]-Y356F-β2 frozen in assay buffer at 77 K (Figure S4). Ground 
state reduction potentials are from ref 50. Values along the diagonal are the calculated 
excited state reduction potentials.
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Figure 5. 
Steady state emission titrations of FnY356 within photoβ2α2 complexes are plotted as 
normalized integrated emission intensity measured over 450–650 nm for 2,3,5-F3Y356 ( ); 
3,5-F2Y356 ( ); 2,3,6-F3Y356 ( ); 2,3-F2Y356 ( ) and fit to Eq. 6 (lines). Samples contained 
5 μM photoβ2, 20 μM wt-α2, 1 mM CDP, 3 mM ATP, in assay buffers described in the 
Methods section, held at 25 °C. The solid lines are the result of fitting the data to Eq. 6.
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Figure 6. 
Correlation of the natural log of kET and ΔG° for photoβ2s alone ( ), or in the presence of 
wt-α2 ( ), or Y731F-α2 ( ). kET and ΔG° were calculated according to Eq.s 2 and 5, 
respectively. Triplicate sets of independently prepared samples contained 10 μM FnY356-
photoβ2 (n = 0–3) or Y356F-photoβ2, 25 μM wt-α2 or Y731F-α2, 1 mM CDP, 3 mM ATP in 
assay buffer at pH 8.2.
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Figure 7. 
Dependence of kPCET on buffer concentration for photoβ2s alone ( ), or in the presence of 
wt-α2 ( ), or Y731F-α2 ( ). kPCET was calculated according to Eq. 2. Triplicate sets of 
independently prepared samples contained 10 μM Y356- or Y356F-photoβ2, 25 μM wt-α2 or 
Y731F-α2, 1 mM CDP, 3 mM ATP in assay buffer containing 15 mM MgSO4, 1 mM EDTA, 
and 50, 100, 150, or 500 mM HEPES buffer adjusted to pH 7.6.
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Figure 8. 
Dependence of k(PC)ET on pH for 2,3-F2Y-photoβ2 alone ( ), or in the presence of wt-α2 
( ), or Y731F-α2 ( ). k(PC)ET was calculated according to Eq. 2. Duplicate sets of 
independently prepared samples contained 10 μM 2,3-F2Y356-photoβ2 or Y356F-photoβ2, 25 
μM wt-α2 or Y731F-α2, 1 mM CDP, 3 mM ATP in assay buffer.
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Figure 9. 
Correlation of the natural ln(kET) with ΔG° for photoβ2 in the presence of wt-α2 ( ), or 
Y731F-α2 ( ). Dashed lines represent simulations of Eq. 8 for β-FnY356s in the presence of 
wt-α2 ( ) and Y731F-α2 ( ), with r = 12.5 Å, λ = 0.98 eV and HAD = 0.051 and 0.044 
cm−1 in the presence of wt- and Y731F-α2, respectively.
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Figure 10. 
Correlation of the ln(kET) with ΔG° for photoβ2 in the absence α2 ( ). Dashed lines 
represent simulations of Eq. 8 for photoβ-FnY356 ( ) and photoβ-Y356 ( ) with λ = 0.74 
eV and 0.90 eV (r = 12.5 Å, HAD = 0.083 cm−1), respectively.
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Scheme 1. 
Photochemical generation of FnY•
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Table 2
pKa values of FnYs within the photoRNR complex
β-Y356Z pKa, complex pKa, free FnYb
2,3,5-F3Y 6.2a 6.4
3,5-F2Y 7.0 7.2
2,3,6-F3Y 7.0 7.0
2,3-F2Y 7.6 7.8
a
Data reproduced from reference 24.
b
Data reproduced from reference 37, determined for N-acetyl C-amide protected flurotyrosine derivatives.
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